Detalhe da pesquisa
1.
Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing matters.
J Surg Oncol
; 129(2): 244-253, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37800378
2.
The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapy.
J Surg Oncol
; 2024 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38801055
3.
Utility of cell-based vaccines as cancer therapy: Systematic review and meta-analysis.
Hum Vaccin Immunother
; 20(1): 2323256, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38544385
4.
Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trials.
Front Immunol
; 14: 1090533, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36960052
5.
Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis.
J Immunother Cancer
; 11(8)2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37536936